Product
Group 3
2 clinical trials
2 indications
Indication
Diabetic Macular EdemaIndication
Celiac DiseaseClinical trial
A Randomized, Double-Masked, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ402 in Participants With Diabetic Macular Edema (DME)Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
A Phase 1B Open-label/Phase 2 Double-blind Placebo- Controlled Study for Pharmacodynamic (PD) Activity, Pharmacokinetics (PK), Safety, and Tolerability of KAN-101 In Patients With Celiac Disease (CeD)Status: Recruiting, Estimated PCD: 2024-12-31